Serum 25-hydroxyvitamin D level is associated with arterial stiffness, left ventricle hypertrophy, and inflammation in newly diagnosed hypertension

Journal of Investigative Medicine

Volumn 61, Issue 6, 2013, Pages 989-994

  Kuloǧlu, Osman ^a   Gür, Mustafa ^a   Şeker, Taner ^a   Kalkan, Gülhan Yüksel ^a   Şahin, Durmuş Yildiray ^a   Tanboǧa, Lbrahim Halil ^b   Koyunsever, Nermin Yildiz ^a   Harbalioǧlu, Hazar ^a   Türkoǧlu, Caner ^a   Akyol, Selahattin ^a   Elbasan, Zafer ^a   Acele, Armaǧan ^a   Çayli, Murat ^a  

^a Numune Training and Research Hospital   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

Aortic stiffness; Hypertension; Pulse wave velocity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE;

ADULT; ARTERIAL STIFFNESS; ARTICLE; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; VITAMIN BLOOD LEVEL; BODY SURFACE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; MALE; MIDDLE AGED; VASCULAR STIFFNESS; VITAMIN D;

EID: 84888387733     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31829a82bc     Document Type: Article

References (53)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
2. Zehnder D, Bland R, Chana RS, et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13:621-629.
3. Burgaz A, Orsini N, Larsson S, et al. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2011;29:636-645.
4. Li YC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003;88:327-331.
5. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184-189.
6. Gur M, Yilmaz R, Demirbag R, et al. Relationship between impaired elastic properties of aorta with left ventricle geometric patterns and left ventricle diastolic functions in patients with newly diagnosed essential hypertension. Int J Clin Pract. 2006;60:1357-1363.
7. Quyyumi AA, Patel RS. Endothelial dysfunction and hypertension: cause or effect? Hypertension. 2010;55:1092-1094.
8. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
9. Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58:186-192.
10. Lee JI, Oh SJ, Ha WC, et al. Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res Clin Pract. 2012;95:42-47.
11. Giallauria F, Milaneschi Y, Tanaka T, et al. Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2012;97:3717-3123.
12. Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology. 2012;51:544-551.
13. Patange AR, Valentini RP, DuW, et al. Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease. Pediatr Cardiol. 2012;33:122-128.
14. Patange AR, Valentini RP, Gothe MP, et al. Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease. Pediatr Cardiol. 2013;34:536-542.
15. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and Management of Osteoporosis: Report of a WHO Scientific Group. Geneva, Switzerland: WHO; 2003.
16. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011.
17. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18:1440-1463.
18. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
19. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618.
20. Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41:105-112.
21. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006;37:243-245.
22. Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990;19:559-563.
23. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
24. Akin F, Ayça B, Köse N, et al. Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med. 2012;60:869-873.
25. Raymond MA, Désormeaux A, Labelle A, et al. Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor. Biochem Biophys Res Commun. 2005;338:1374-1382.
26. Wu-Wong JR, Nakane M, Ma J, et al. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis. 2006;186:20-28.
27. Zehnder D, Bland R, Chana RS, et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13:621-629.
28. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-238.
29. McEniery CM, McDonnell BJ, So A, et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension. 2009;53:524-531.
30. Dao H, Essalihi R, Bouvet C, et al. Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res. 2005;66:307-317.
31. Hutchinson MS, Grimnes G, Joakimsen RM, et al. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol. 2010:162:935-942.
32. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65:225-236.
33. Giallauria F, Ling SM, Schreiber C, et al. Arterial stiffness and bone demineralization: the Baltimore longitudinal study of aging. Am J Hypertens. 2011;24:970-975.
34. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:E10YE17.
35. Aikawa E, Aikawa M, Libby P, et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation. 2009;119:1785-1794.
36. Hofbauer LC, Brueck CC, Shanahan CM, et al. Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int. 2007;18:251-259.
37. Cirillo M, Ciacci C, De Santo NG. Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med. 2008;359:864-866.
38. Faroqui S, Levi M, Soleimani M, et al. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int. 2008;73:1141-1150.
39. Foley RN, Collins AJ, Herzog CA, et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397-404.
40. Ix JH, De Boer IH, Peralta CA, et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol. 2009;4:609-615.
41. Vermeersch SJ, Rietzschel ER, De Buyzere ML, et al. Age and gender related patterns in carotid-femoral PWV and carotid and femoral stiffness in a large healthy, middle-aged population. J Hypertens. 2008;26:1411-1419.
42. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009;4:1515-1522.
43. O'Connell TD, Berry JE, Jarvis AK, et al. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol. 1997;272:H1751YH1758.
44. Chen S, Law CS, Grigsby CL, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838-1847.
45. Mancuso P, Rahman A, Hershey SD, et al. 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J Cardiovasc Pharmacol. 2008;51:559-564.
46. Matias PJ, Jorge C, Ferreira C, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5:905-911.
47. Wu J, Garami M, Cheng T, et al. 1,25(OH)2-vitamin D3 and retinoic acid antagonize endothelin-stimulated-hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996;97:1577-1588.
48. Ameri P, Canepa M, Milaneschi Y, et al. Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med. 2013;273:253-262.
49. Guillot X, Semerano L, Saidenberg-Kermanac'h N, et al. Vitamin D and inflammation. Joint Bone Spine. 2010;77:552-557.
50. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation. 2009;120:687-698.
51. Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009;53:323-330.
52. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142-1148.
53. Oudshoorn C, van der Cammen TJ, McMurdo ME, et al. Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation. Br J Nutr. 2009;101:1597-1606.